Ligand-Mediated Targeting of Cytokine Interleukin-27 Enhances Its Bioactivity In Vivo-Reference-Cited by-同舟云学术

Ligand-Mediated Targeting of Cytokine Interleukin-27 Enhances Its Bioactivity In Vivo

Published:2020-06 Issue: Volume:17 Page:739-751
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Figueiredo Marxa L.,Figueiredo Neto Manoel,Salameh Janelle Wes,Decker Richard E.,Letteri Rachel,Chan-Seng Delphine,Emrick Todd

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference40 articles.

1. Combination of Interleukin-27 and MicroRNA for Enhancing Expression of Anti-Inflammatory and Proosteogenic Genes;Figueiredo Neto;Arthritis (Egypt),2017

2. Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo;Zolochevska;Hum. Gene Ther.,2011

3. Interleukin-27 expression modifies prostate cancer cell crosstalk with bone and immune cells in vitro;Zolochevska;J. Cell. Physiol.,2013

4. Interleukin-27 gene delivery for modifying malignant interactions between prostate tumor and bone;Zolochevska;Hum. Gene Ther.,2013

5. Editorial: IL-27 expression following TLR activation in bone: sounding the alarm for repair;Figueiredo;J. Leukoc. Biol.,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in microbubble-assisted ultrasound-guided gene therapy: Mechanisms and applications;Science China Materials;2024-07-02

2. IL-27 expression regulation and its effects on adaptive immunity against viruses;Frontiers in Immunology;2024-06-20

3. Cabozantinib and IL-27 combinatorial therapy for bone-metastatic prostate cancer;Frontiers in Molecular Biosciences;2023-09-28

4. An engineered interleukin‐11 decoy cytokine inhibits receptor signaling and proliferation in lung adenocarcinoma;Bioengineering & Translational Medicine;2023-07-18

5. Targeted Microbubbles for Drug, Gene, and Cell Delivery in Therapy and Immunotherapy;Pharmaceutics;2023-05-30